CVE-2026-76243: eidetic-labs stigmem · Improper Authorization
Affects eidetic-labs stigmemSource CVE Database V5
Not known to be exploited · CVSS 9.2 Critical : upgrade to 0.9.0a2 as a priority.
Data as of 16 Nov 2026, 20:25 UTC
- EPSS
- 0.5% chance of exploitation in 30 days – higher than 47% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in 0.9.0a2
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 19 Aug 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 16 Nov 2026.
What to do
Upgrade eidetic-labs stigmem to 0.9.0a2.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| eidetic-labsstigmem | Affected
| Fixed in
|
GitHubeidetic-labs/stigmempkg:github/eidetic-labs/stigmemOther threats | Affected
| Fixed in– |
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
If you cannot patch yet, avoid disabling authentication on non-loopback deployments and restrict exposure of stigmem nodes to trusted environments only.
Description
stigmem versions before 0.9.0a2 and version 0.9.0 have an improper authorization vulnerability that allows unauthenticated access when authentication is disabled on non-loopback deployments. This enables attackers to perform read, write, and federation operations anonymously if nodes are exposed outside local development environments.